GTG 6.98% 4.0¢ genetic technologies limited

what's going on?, page-3

  1. 3,085 Posts.
    lightbulb Created with Sketch. 47
    Could have something to do with the RBS Morgans analyst report pulled back on their expectation of Brevagen roll-out.


    http://www.gtglabs.com.au/images/stories/pdf/Reports/GTG120228_Steady_progress_RBS_Morgans_Feb_2012.pdf

    A little to early a call imo, time will tell.
    :-)


 
watchlist Created with Sketch. Add GTG (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.